Our 2022 outlook for life sciences real estate

A record $70 billion of private and public capital poured into the life sciences industry in 2020. Watch our Chief Investment Officer discuss the opportunities we see for investors in life sciences real estate.

 

 

 

In this video, our Chief Investment Officer Ian Formigle talks about the outlook for life sciences real estate in 2022. We see opportunities for this highly specialized real estate near urban environments, especially in areas with top talent, high intellectual capital, and the presence of top research universities. Learn more about our take on this in-demand asset class in our Investment Thesis.  

Related content >

All information provided through the education center is for educational purposes only and does not constitute investment, legal, or tax advice, or an offer to buy or sell any security or investment product. The information contained herein has been obtained from sources we believe to be reliable but is not guaranteed as to its accuracy or completeness. The articles in this education center are written by employees of CrowdStreet and have been prepared solely for informational purposes. Any videos presented are for educational purposes only and do not constitute investment advice. Whenever there are hyperlinks to third-party content, this information is intended to provide additional perspective and should not be construed as an endorsement of any services, products, guidance, individuals or points of view outside of Crowdstreet. All examples are hypothetical and for illustrative purposes only.